OPKO Health
OPK
#5857
Rank
ยฃ0.79 B
Marketcap
ยฃ1.01
Share price
-0.74%
Change (1 day)
-18.25%
Change (1 year)

OPKO Health (OPK) - P/B ratio

P/B ratio as of December 2025 : 0.8208

According to OPKO Health 's latest financial reports the company has a price-to-book ratio of 1.669.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

OPKO Health - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-310.7292-13.21%
2023-12-310.840335.86%
2022-12-310.6185-68.2%
2021-12-311.9422.84%
2020-12-311.58159.64%
2019-12-310.6098-38.11%
2018-12-310.9852-33.73%
2017-12-311.49-40.02%
2016-12-312.48-10.41%
2015-12-312.77-46.44%
2014-12-315.1729.52%
2013-12-313.99-44.83%
2012-12-317.23-5.82%
2011-12-317.68-81.12%
2010-12-3140.7176.69%
2009-12-3114.7-98.36%
2008-12-318972861.26%
2007-12-3130.3-95.6%
2006-12-3168886593.57%
2005-12-310.793341.35%
2004-12-310.5612-59.04%
2003-12-311.37288.78%
2002-12-310.3524

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
6.15 648.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
4.25 418.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
2.47 201.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
4.48 445.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Alnylam Pharmaceuticals
ALNY
258 31,352.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.73 598.35%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
2.47 201.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
9.26 1,028.15%๐Ÿ‡บ๐Ÿ‡ธ USA